VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Varian Medical Systems, Inc.

3100 Hansen Way
Palo Alto, CA 94304
United States

Sector : Healthcare
Industry : Medical Instruments & Supplies
Full Time Employees : 9,200

Key Executives

Name Title Pay Exercised Year Born
Mr. Dow R. Wilson Pres, CEO & Director 3.28M 7.54M 1959
Mr. Gary E. Bischoping Jr. Sr. VP of Fin. & CFO 1.32M N/A 1968
Mr. John W. Kuo Sr. VP, Gen. Counsel & Corp. Sec. 1.16M 1.02M 1963
Ms. Kolleen T. Kennedy Chief Growth Officer & Pres of Proton Solutions 1.83M 661.53k 1959
Mr. Kevin O'Reilly Sr. VP of Global Operations N/A N/A N/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions; strategic cooperation framework agreement with Shandong Cancer Hospital for proton therapy clinical application and research in China; collaboration with Tennessee Oncology, PLLC for the implementation of Noona, a software application for managing patient symptoms and capturing patient reported outcomes in cancer care; and partnership with International Atomic Energy Agency. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Corporate Governance

Varian Medical Systems, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 2; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.